Sort
326,823 grants matching “clinical trial”
Clinical Trials Transformation Initiative
$1,999,997Robert Califf · Duke University · U19 · FY2013 · FD
FY24 SBIR PHASE IITOPIC NO. 423 PROJECT TITLE: "PASSIVE AND ACTIVE AI SCREENING FOR SOCIAL DETERMINANTS OF HEALTH AND INTERVENTIONS TO IMPROVE OUTCOMES IN THE CANCER PATIENT POPULATION".
$1,999,994Ruben Amarasingham · Pieces Technologies, Inc. · N44 · FY2024 · CA
TOPIC 414 : SYNTHETIC BIOLOGY GENE CIRCUITS FOR CANCER THERAPY
$1,999,993Gary Lee · Senti Biosciences, Inc. · N44 · FY2021 · CA
A Prospective Natural History Study of Angelman Syndrome: A Fresh Approach to a 10-year Longitudinal Study to Facilitate Development of Novel Therapeutic Products
$1,999,988Wen-Hann Tan · Boston Children'S Hospital · R01 · FY2017 · FD
"Targeted Ac-225-radiopharmaceutical for metastatic uveal melanoma"Period of Performance: 9/18/2017 - 9/17/2019
$1,999,987Rikki Waterhouse · Modulation Therapeutics, Inc. · N44 · FY2017 · CA
RadTox - Measuring Radiation Toxicity using Circulating DNA
$1,999,984Aiguo Zhang · Diacarta, Llc · N01 · FY2018 · CA
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$1,999,984Barbara Driver · Westat, Inc. · N01 · FY2025 · HD
Combating Subclonal Evolution of Resistant Cancer Phenotypes
$1,999,948Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2019 · CA
The UCLA Center for In Vivo Imaging in Cancer Biology
$1,999,943University Of California Los Angeles · P50 · FY2005 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care
$1,999,936Jane C. Weeks · Dana-Farber Cancer Inst · RC2 · FY2009 · CA
IGF::OT::IGF (CHAMPIONS ONCOLOGY)To address the slow growth rate of prostate PDXs by eliminating logistical barriers through development of CDX (i.e., PDX from circulating tumor cells) models. PERIOD
$1,999,931Peter Kipp · Champions Oncology, Inc. · N44 · FY2017 · CA
NEW AWARD DISTRO. FALL-RELATED HEALTH OUTCOMES IN LOWER LIMB PROSTHESIS USERS: A PRAGMATIC CLINICAL TRIAL TO ASSESS EFFECTIVENESS OF MICROPROCESSOR-CONTROLLED PROSTHETIC KNEES.
$1,999,931University Of Washington · · FY2020 · Defense Health Agency
OTHER FUNCTIONS DEVELOPMENT OF TOOLS FOR CRYOGENIC BIOPSY OF SOFT TISSUE.
$1,999,928Erez Nevo · Robin Medical, Inc. · N44 · FY2012 · CA
Comparative effectiveness of breast imaging strategies in community practice
$1,999,896Diana L Miglioretti · Kaiser Foundation Health Plan Of Washington · RC2 · FY2009 · CA
Centers for Intervention Development and Applied Research (CIDAR)
$1,999,879William T. Carpenter · University Of Maryland Baltimore · P50 · FY2008 · MH
Phosphate binder therapy and chronic kidney disease in children
$1,999,823Isidro B. Benjamin Salusky · University Of California Los Angeles · U01 · FY2021 · DK
TOPIC 368: TREATMENT OPTIMIZATION BY COMBINED A-EMITTER (ARPT)/RADIOTHERAPY (XRT) DOSIMETRY FOR PROSTATE CANCER PATIENTS
$1,999,796Michael Ghaly · Radiopharmaceutical Imaging And Dosimetry, Llc · N44 · FY2019 · CA
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
$1,999,788Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
ECHO Administrative Supplement - Neonatal Opioid Trials
$1,999,671Phillip Brian Smith · Duke University · U2C · FY2022 · OD
IGF::OT::IGF Topic 090, Phase II, Devices to Close Ductus Arteriosus in Premature Infants IGF::OT::IGF
$1,999,623Paul Lubock · · N44 · FY2017 · HL
Using Clinical Treatment Data in a Machine Learning Approach for Sepsis Detection
$1,999,554Jana Hoffman · Dascena, Inc. · R44 · FY2021 · AA
On-demand nonhormonal male contraception via ADCY10 inhibition
$1,999,520Lonny R Levin · Weill Medical Coll Of Cornell Univ · P50 · FY2024 · HD
On-demand nonhormonal male contraception via ADCY10 inhibition
$1,999,520Lonny R Levin · Weill Medical Coll Of Cornell Univ · P50 · FY2025 · HD
On-demand nonhormonal male contraception via ADCY10 inhibition
$1,999,520Lonny R Levin · Weill Medical Coll Of Cornell Univ · P50 · FY2023 · HD
IMAGING AUTOIMMUNE DISEASE
$1,999,518Diane J Mathis · Harvard Medical School · P01 · FY2012 · AI